Aerie Pharma (AERI) Tops Q1 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q1 Adj. EPS of ($0.62), $0.05 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79